NT-proBNP levels can guide heart failure therapy decisions and monitor treatment response, with serial measurements tracking whether drug adjustments are improving cardiac function.
Key findingNT-proBNP serves as both a diagnostic tool and a treatment monitoring biomarker in heart failure, with serial measurements guiding drug titration and
What the researchers found
NT-proBNP serves as both a diagnostic tool and a treatment monitoring biomarker in heart failure, with serial measurements guiding drug titration and tracking therapeutic response for personalized care.
Why it matters
Relevant for natriuretic-peptides, cardiovascular, clinical-trials.
How the study worked
review study on natriuretic-peptides, cardiovascular.
What this study cannot tell us
See abstract.
How to read the evidence
moderate evidence.
When this study was published
Published in 2004.
The bigger picture
Advances peptide research.
Questions still open
- Further research needed.
- Clinical translation to evaluate.
Common questions
What was studied?
What was found?
Read the original research
NT-proBNP in heart failure: therapy decisions and monitoring.
European journal of heart failure, 6(3), 351-4
Citation
Richards, Mark; Troughton, Richard W. (2004). NT-proBNP in heart failure: therapy decisions and monitoring.. European journal of heart failure, 6(3), 351-4.